Cumulative data point to a key role of Ca 2+ -dependent gliotransmitter release as a modulator of neuronal networks. Here, we tested the hypothesis that astrocytes in response to agonist exposure also release lipid modulators through Ca 2+ -independent phospholipase A2 (iPLA2) activity. We found that cultured rat astrocytes in response to agonist exposure, released Arachidonic Acid (AA) and/or its derivatives, including the endogenous cannabinoid, 2arachidonoyl-sn-glycerol (2AG) and the prostaglandin PGE2. Surprisingly, buffering of cytosolic Ca 2+ was linked to a sharp increase in astrocytic lipid release. In addition, astrocytic release of PGE2 enhanced mEPSPs by inhibiting the opening of neuronal Kv channels in acute brain slices.
INTRODUCTION
Comprising the majority weight of the adult brain, lipids are an essential component of the phospholipid bilayer and, of that, a large percentage are in the form of long chain polyunsaturated fatty acids (PUFA), mainly Arachidonic Acid (AA) and Docosahexaenoic Acid (DHA) (Sinclair, 1975) . The liver is the major organ in the body for synthesis of AA, but the brain is also capable of producing AA and DHA from their precursor fatty acids, linoleic and linolenic acids (Dhopeshwarkar and Subramanian, 1976) . Astrocytes play a pivotal role in this process. Through their vascular endfeet, astrocytes have prime access to incoming fatty acid precursors as they cross the blood brain barrier (BBB) and serve as the major site for processing essential fatty acids in the CNS (Moore, 1993) . Astrocytes also play a key role in macroscopic distribution of lipids via perivascular glymphatic fluxes (Rangroo Thrane et al., 2013a; Plog and Nedergaard, 2018) .
Lipids have gained much attention for their role as bioactive mediators in the CNS (Carta et al., 2014; Ledo et al., 2019) . Numerous studies have focused on lipids in both functional hyperemia and synaptic activity. For instance, PGE2 has been shown to be a potent vasodilator and vasoconstrictor in CNS blood flow regulation (Zonta et al., 2003; Takano et al., 2006; Gordon et al., 2007; Dabertrand et al., 2013; MacVicar and Newman, 2015; Czigler et al., 2019) , as well as a regulator of membrane excitability in CA1 pyramidal neurons during synaptic activity . Furthermore, AA and its derivatives are important secondary messengers that can modulate the activity of a variety of ion channels (Piomelli, 1993; Meves, 1994; Horimoto et al., 1997; Boland and Drzewiecki, 2008; Cordero-Morales and Vasquez, 2018) . For example, the endocannabinoid, 2AG can suppress neurotransmitter release from the presynaptic membrane through the activation of cannabinoid receptor 1 (CB1) (Fride, 2002; Hashimotodani et al., 2007; Smith et al., 2019) . In addition, PGE2 has been shown to suppress Kv current in sensory neurons (Nicol et al., 1997; Evans et al., 1999) , whereas AA suppresses Kv channels in the soma or dendrites of pyramidal neurons, and therefore, broadens presynaptic action potentials (Carta et al., 2014) and enhances EPSPs (Ramakers and Storm, 2002) . However, these studies focused on neuronal lipid release effects on synaptic activity and paid little or no attention to the fact that astrocytic lipid mediators via receptor-mediated pathways may also influence synaptic activity.
Given that the majority of AA, DHA, and other lipids present in the extracellular fluid are produced by astrocytes (Moore et al., 1991) , it is crucial to establish whether astrocytic lipid release actively modulates synaptic activity.
In culture, astrocytes can release AA in a cPLA2 Ca 2+ -dependent pathway upon activation of metabotropic glutamate and P2Y purine receptors (Bruner and Murphy, 1990; Stella et al., 1994; Stella et al., 1997; Chen and Chen, 1998 ). In addition, astrocytes also express the Ca 2+independent PLA2 (iPLA2) (Sun et al., 2005) . This PLA2 isoform, like cPLA2, is activated by the Gprotein βγ subunit (iPLA2) (Jelsema and Axelrod, 1987; Murayama et al., 1990; van Tol-Steye et al., 1999) , but does not require Ca 2+ or PKC phosphorylation for activation (Winstead et al., 2000) .
iPLA2 has also been shown to release AA and DHA upon receptor stimulation in numerous cell types Portilla et al., 1994; Akiba et al., 1998; Seegers et al., 2002; Tay and Melendez, 2004) . However, to our knowledge, the role of iPLA2 has yet to be fully explored in astrocytes.
Previous work in our lab and many others had demonstrated that astrocytes are capable of releasing gliotransmitters upon agonist stimulation. However, the question of whether astrocytes play a significant role in modulating synaptic activity is still controversial. Recent studies with genetically encoded calcium indicators enabled us to identify localized Ca 2+ signals within fine processes, and have confirmed Ca 2+ -dependent astrocytic effects on synaptic activity (Yu et al., 2018) . However, the existence of Ca 2+ -independent lipid signaling in astrocytes is still not clear. In this study, we assessed the existence of Ca 2+ -independent lipid signaling in astrocytes and asked whether astrocytic lipid release can modulate synaptic transmission. Our analysis showed that upon Ca 2+ chelation and receptor stimulation astrocytes can release lipids through iPLA2 activation and that these lipids potentiate synaptic activity. These observations expand our understanding of how astrocytes can shape rapid synaptic events.
MATERIALS and METHODS

Culture
Cultured neocortical astrocytes were prepared from 1 to 2 day old Wistar rat pups (Taconic Farms, Inc.) of either sex as previously described (Lin et al., 1998) . Briefly, cerebral cortices were dissected, and meninges were removed. The tissue was washed 3 times in Hanks' balanced salt solution without Ca 2+ . Once washed the tissue was triturated, filtered through 70 µm nylon mesh and then centrifuged. The pellet was resuspended in 10 % FBS in DMEM/F12 containing 100 IU ml 1 penicillin and 100 µg ml -1 streptomycin, and transferred to culture flasks. Cells were maintained at 37˚C in an incubator containing humidified air and 5% CO2. Medium was changed after 24 hrs and twice a week thereafter. More than 95% of the cells stained positive for GFAP.
When the cells became confluent, they were rinsed two times in Hanks' balanced salt solution without Ca 2+ , suspended in 0.05 % trypsin-containing solution for 1 min, resuspended in DMEM/F12, centrifuged to remove trypsin, and then plated in 24-well plates. Experiments were performed when the cells were 95% confluent.
Viral Vectors and Viral Transductions
Viral vectors driving GFAP cyto-GCaMP6f (Baljit S. Khakh) were obtained from the University of Pennsylvania Vector Core (AAV 2/5 serotype). Secondary rat astrocytic cultures were transduced with AAV GFAP cyto-GCaMP6f. After transduction, the cells were allowed to incubate at 37˚C for 5 days prior to Ca 2+ imaging experiments.
Ca 2+ imaging
Cultured cells in 24-well plates were transduced with AAV GFAP cyto-GCaMP6f and incubated with various pharmacological agents for 30 minutes at 37˚C. Using confocal microscopy (Olympus FV500), calcium wave activity was evoked by adding equal volume of medium containing 100µM of ATP to each well. Relative increases in fluorescence signal evoked by agonist exposure over baseline fluoresce (ΔF/F) were calculated as previously described (Nedergaard, 1994; Smith et al., 2018) .
Radiolabeling and Assessment of AA Release
Confluent rat astrocytic cultures were incubated with 100nCi 3 H-AA overnight prior to experiments.
The cells were washed three times with serum-free medium. After washes, the cells were allowed to recover for 20 minutes. Before stimulation with 100 µM of ATP, the cells were incubated with appropriate inhibitors for 10 to 12 minutes. Aliquots of medium were taken 15 minutes after stimulation and 3 H-AA and/or its derivatives were measured by liquid scintillation counting.
HPLC/MS/MS analysis of lipids
Confluent rat astrocytes were washed with serum-free media and then allowed to recover for 1 hr in serum-free media. At this time cells were either incubated with vehicle or 20 µM CPA for 15 minutes and then challenged with 100 µM of ATP or vehicle for 15 minutes in the same protocol as the above radiolabeled experiments. Media was then removed and retained, 2 ml of HPLCgrade methanol was added to the flask for 5 minutes, removed and retained. An additional 2 ml of HPLC-grade methanol was added, cells were scraped and then this mixture was added to the previously two retained fractions. 200 pM deuterium-labeled standards were added, then samples were centrifuged at 19,000 x g in 24C. Lipids in the eluent were partially purified on 500mg C18
Bond Elut solid phase extraction columns (Varian), concentrated into methanolic fractions of 40%, 60%, 85%, and 100%, then analyzed using HPLC/MS/MS (Shimadzu SCL10Avp-Wilmington, DE, USA; API 3000 Applied Biosystems/MDS SCIEX, Foster city, CA, USA) as previously described (Leishman et al., 2018) . Over 50 lipids were targeted in these screens including 40 lipoamines, 3 acyl glycerols, 2 free fatty acids, and 2 prostaglandins. It was determined in pilot studies that the signal detection of lipids in the media was too low for analysis of media alone; however, the signal with both the media and cells was more than sufficient to perform a large-scale analysis; therefore, the media and the cells were combined before the lipid extraction as outlined above.
PGE2 Release Assessment via PGE2 Immunoassay
Confluent rat astrocytic cultures were washed 3 times with serum-free medium. After washes, the cells were allowed to recover for 20 minutes. Before stimulation with 100 µM of ATP, the cells were incubated with appropriate inhibitors for 10 to 12 minutes. Aliquots of medium were taken 15 minutes after stimulation and measured using a PGE2 Enzyme Immunoassay Kit from Cayman Chemicals following the manufacturer's manual.
Western Blot
Samples harvested from 24-well plates were separated by SDS-PAGE and transferred to nitrocellulose. Membranes were blocked with Tris-buffered saline containing 0.05% (wt/vol) Tween 20 and 5% nonfat dry milk. The primary antibodies were anti-iPLA2 (Sigma, St. Louis, MO), anti-b-actin (Cell Signaling, Danvers, MA), at 1:1000 to 1:2000 dilutions in blocking buffer.
Detection of chemiluminescence from horseradish peroxidase-linked secondary antibodies was performed using the ChemiDoc™ XRS+ System and running Image Lab™ software.
Isolation of human fetal astrocytes
Human fetal forebrain tissues were obtained from second-trimester aborted fetuses of 20 weeks gestational age. Tissues were obtained from aborted fetuses, with informed consent and tissue donation approval from the mothers, under protocols approved by the Research Subjects Review Board of the University of Rochester Medical Center. No patient identifiers were made available to or known by the investigators; no known karyotypic abnormalities were included. The forebrain tissue samples were collected and washed 2-3 times with sterile Hank's balanced salt solution with Ca 2+ /Mg 2+ (HBSS +/+ ). The cortical plate region (CTX) of fetal forebrain was dissected and separated from the ventricular zone/subventricular zone (VZ/SVZ) portion. The CTX was then dissociated with papain as previously described (Keyoung et al., 2001) . The cells were resuspended at 2-4 x 10 6 cells/ml in DMEM/F12 supplemented with N2, 0.5 % FBS and 10 ng/ml bFGF and plated in suspension culture dishes. The day after dissociation, cortical cells were recovered and subjected to magnetic activated cell sorting (MACS) for purification of the astrocyte progenitor population. Briefly, the recovered cells were incubated with CD44 microbeads as per the manufacturer's recommendations (Miltenyi Biotech). The cells were then washed, resuspended in Miltenyi Washing buffer and bound to a magnetic column (Miltenyi Biotech). The bound CD44+ astrocyte progenitor cells were eluted, collected and then washed with DMEM/F12. The purified human fetal astrocyte progenitors were cultured in DMEM/F12 supplemented with N2 and 5% characterized FBS to further differentiate them. To prepare culture dishes for PGE2 immunoassays or immunocytochemistry, the fetal cortical astrocytes were dissociated with TrypLE (Invitrogen) into single cells and then plated onto poly-L-ornithine/laminin coated 24-well plates (50,000 cells per well).
shRNA Lentiviral knockdown of iPLA2 in astrocytes
Rat astrocytes cultures were plated in a 24-well plate and grown to approximately 50% confluency. According to the manufacturer's instructions with modifications, the cultures were transduced overnight by adding either group VI iPLA2 shRNA (r) lentiviral particles (sc-270117-V) or control shRNA lentiviral particles-A (sc-108080) directly to the culture medium containing polybrene (sc-134220) (all from Santa Cruz Biotechnology, Santa Cruz). 24 hrs after transfection, the culture medium was removed and fresh culture medium without polybrene was added.
Experiments and western blot analysis were performed 7 days after transduction.
Acute Hippocampal Slice preparation and Electrophysiology
Unless otherwise noted, 15-21 day old C57BL/6 (Charles River, Wilmington, MA), MrgA1 +/transgenic, and littermate control MrgA1 -/pups (courtesy of Dr. Ken McCarthy) (Fiacco et al., 2007) of either sex were used for preparation of hippocampal slices as previously described (Wang et al., 2012) . The pups were anesthetized in a closed chamber with isoflurane (1.5%), and decapitated. The brains were rapidly removed and immersed in ice-cold cutting solution that contained (in mM): 230 sucrose, 2.5 KCl, 0.5 CaCl2, 10 MgCl2, 26 NaHCO3, 1.25 NaH2PO4, and 10 glucose, pH=7.2-7.4. Coronal slices (400 μm) were cut using a vibratome (Vibratome Company, St. Louis) and transferred to oxygenated artificial cerebrospinal fluid (aCSF) that contained (in mM): 126 NaCl, 4 KCl, 2 CaCl2, 1 MgCl2, 26 NaHCO3, 1.25 NaH2PO4, and 10 glucose, pH = 7.2-7.4, osmolarity = 310 mOsm. Slices were incubated in aCSF for 1-5 hours at room temperature before recording. Experiments were performed at room temperature (21-23 ˚C). During the recordings, the slices were placed in a perfusion chamber and superfused with aCSF gassed with 5% CO2 and 95% O2 at room temperature. Cells were visualized with a 40X water-immersion objective and differential inference contrast (DIC) optics (BX51 upright microscope, Olympus Optical, New York, NY). Patch electrodes were fabricated from filament thin-wall glass (World Precision Instruments) on a vertical puller; resistance of the pipette is around 6-9 MΩ with intracellular pipette solution added. I-V curves of voltage-gated potassium currents were recorded under voltage-clamp using an AxoPatch MultiClamp 700B amplifier (Axon Instruments, Forster City, CA). The pipette solution contained (in mM) 140 K-gluconate, 5 Naphosphocreatine, 2 MgCl2, 10 HEPES, 4 Mg-ATP, 0.3 Na-GTP (pH adjusted to 7.2 with KOH).
When measuring outward currents, QX314 (0.5 mM) was added to the pipette solution to block Na + currents. For recordings of miniature EPSPs (mEPSPs) 0.5 µM TTX was added in the aCSF.
The junction potential between the patch pipette and bath solution was zeroed before forming a giga-seal. Patches with seal resistances of less than 1 GΩ were rejected. Data were low-pass filtered at 2 kHz and digitized at 10 kHz with a Digidata 1440 interface controlled by pClamp Software (Molecular Devices, Union City, CA).
Pharmacological agents used in cultures and slice experiments
Adenosine 5'-triphosphate (ATP, 100 µM); Cyclopiazonic acid (CPA, 20 µM); trans-(1S, 3R)-1-Amino-1, 3-cyclopentanedicarboxylic acid (t-ACPD, 100 µM); (±)-α-Amino-3-hydroxy-5methylisoxazole-4-propionic acid hydrobromide ((±)-AMPA, 100 µM); Prostaglandin E2 (PGE2, 50 µM, Tocris); Phe-Met-Arg-Phe amide (FMRF, 15 µM); Thr-Phe-Leu-Leu-Arg-NH2 (TFLLR-NH2, 30 µM, Tocris); N-Acetyl-Asp-Glu (NAAG, 100 µM); (1R, 4R, 5S, 6R)-4-Amino-2-oxabicyclo [3.1.0] hexane-4,6-dicarboxylic acid disodium salt (LY379268, 100 µM, Tocris); Calmidazolium chloride (CMZ, 2 µM, Tocris); Methyl arachidonyl fluorophosphonate (MAFP, 10 µM); Bromoenol lactone (Bel, 10 µM); Arachidonic Acid (AA, 50 µM); N- (2, triethylammonium chloride (QX314, 1mM, Tocris); 4-(4-,9-Diethoxy-1,3-dihydro-1-oxo-2Hbenz[f]isoindol-2-yl)-N-(phenylsulfonyl) benzeneacetamide (GW627368X 3 µM, Tocris); 6-Isopropoxy-9-xanthone-2-carboxylic acid (AH6809, 10 µM, Tocris); N-(Piperidin-1-yl)-5-(4iodophenyl)-1-(2,4-dichlorophenyl)-4-methyl-1H-pyrazole-3-carboxamide (AM251, 5 µM, Tocris); Tetrodotoxin (TTX, 0.5 µM, Tocris); 1,2-Bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid (Bapta, 50 µM, Tocris); and 1,2-Bis(2-aminophenoxy)ethane-N,N,N',N'-tetra-acetic acid tetrakis (acetoxymethylester) (BAPTA-AM, 20 µM). All chemicals were from Sigma unless otherwise noted. All results are reported as mean ± s.e.m.
Statistical analysis of data
RESULTS
GPCR-mediated Ca 2+ -independent release of 3 H-AA and its derivatives from astrocytic cultures
We first assessed the efficiency by which preloading with inhibitor of the endoplasmic reticulum (ER) Ca 2+ pump cyclopiazonic acid (CPA) (20 µM) or the cytosolic Ca 2+ chelator 1,2-bis(oaminophenoxy)ethane-N,N,N′,N′-tetraacetic acid (acetoxymethyl ester) (BAPTA-AM) (20 µM) blocked ATP (100 µM) induced cytosolic Ca 2+ in cultured rat astrocytes. Imaging cytosolic Ca 2+ (AAV GFAP cyto-GCaMP6f) showed that the purine agonist ATP (100 µM) induced a prompt increase in Ca 2+ that was completely blocked in CPA and BAPTA loaded cultures, whereas 10 µM Methylarachidonyl Fluorophosphates (MAFP), a nonspecific inhibitor of both cPLA2 and iPLA2 or 10 µM of Bromoenol Lactone (Bel) (Cornell-Bell et al.), a specific inhibitor of iPLA2 did not affect ATP induced Ca 2+ rises in cultures ( Figure 1A-B) .
As a broad-based approach to AA-specific lipidomics, Ca 2+ -independent release of AA and/or its derivatives was performed using a 3 H-AA assay ( Figure 1C ). Cultured rat astrocytes were preincubated overnight with 3 H-AA, providing sufficient time for 3 H-AA to be incorporated in multiple biosynthetic and metabolic pathways including membrane phospholipids, which are precursors for endocannabinoids, and related lipids that are themselves precursors to AA release (Chen and Chen, 1998; Strokin et al., 2003) . Therefore, this assay serves to determine if any AA derivatives (precursors or metabolites) from the 3 H-AA that was incorporated into the cell are being released and all such lipids species will be referred to hereafter as 3 H-AA labeled metabolites. ATP on its own failed to induce the release of 3 H-AA that was within the level of detection ( Figure 1D ); however, in cultures pretreated for 10 to 12 minutes with CPA or BAPTA-AM, ATP evoked a robust increase in the release of 3 H-AA, whereas CPA alone had no effect ( Figure 1D) . Similarly, we found that upon stimulation with a combination of tACPD (100 µM), an mGluR agonist, and AMPA (100 µM), an ionotropic GluR agonist, we observe a significant release of 3 H-AA when cytosolic calcium was blocked with CPA, but not in cultures not pretreated with CPA ( Figure 1E) . These observations confirm that rat astrocytes can release AA derivatives, key precursors of bioactive eicosanoids (Strokin et al., 2003; Rosenegger et al., 2015) , but that AA release is, surprisingly, inhibited by increases in cytosolic Ca 2+ . iPLA2 activity is essential for calcium independent liberation of AA-derived lipids.
To explore the mechanism of Ca 2+ -independent release of 3 H-AA, we next evaluated whether inhibition of the Ca 2+ -sensitive cPLA2 or alternatively of the Ca 2+ -insensitive iPLA2 enzymes would reduce 3 H-AA release. Astrocytes were pretreated with 10 µM of MAFP or 10 µM of BEL. MAFP significantly decreased the release of 3 H-AA in response to ATP in cultures exposed to CPA ( Figure 1F) . Similarly, Bel suppressed release of 3 H-AA, thus confirming a role for iPLA2 in Ca 2+independent lipid release ( Figure 1F) . 3 H-AA release was only observed when agonist-induced increases in cytosolic Ca 2+ were blocked ( Figures 1D-E ), suggesting that intracellular Ca 2+ inhibits the Ca 2+ -independent iPLA2.
Calmodulin is a potent Ca 2+ -dependent inhibitor of iPLA2 (Wolf and Gross, 1996) . To assess the interaction between calmodulin and iPLA2, the cells were treated with Calmidazolium (CMZ), an inhibitor of Ca 2+ /calmodulin interaction that has been shown to remove the calmodulin block of iPLA2 (Wolf and Gross, 1996) . In the presence of CMZ (2 μM), ATP led to a significant release of 3 H-AA, which was comparable to blocking increases in cytosolic Ca 2+ by preloading with either CPA or BAPTA ( Figure 1E ). This observation suggests that Ca 2+ acts primarily as a brake, through calmodulin, that effectively inhibits iPLA2 activity (Wolf and Gross, 1996; Wolf et al., 1997) . These findings are consistent with previous studies showing that iPLA2 is involved in receptor-mediated AA release in pancreatic islet cells , smooth muscle cells (Lehman et al., 1993) , and endothelial cells (Seegers et al., 2002) . Taken together, these data provide evidence of a new signaling mechanism in astrocytes through Ca 2+ -independent iPLA2, which is the major PLA2 isoform in the brain and accounting for 70% of total PLA2 activity (Yang et al., 1999) .
Targeted lipidomics reveals multiple lipid species produced in cultured astrocytes through
Ca 2+ independent mechanisms
Using lipid extraction and partial purification methods coupled to HPLC/MS/MS, targeted lipidomics screens were performed on cultured astrocytes that were incubated with CPA and then challenged with ATP and compared to vehicle controls. Of the 50 lipids that were screened, 30
were present in each of the samples and could be used for comparative analyses. Table 1 lists all of the actual values as mean ±SEM (Figure 2A) . Figure 2A derivatives were significantly increased, including the endocannabinoids, anandamide and 2-AG, though the most dramatic increases were of the prostaglandin, PGE2. Figure 2D shows representative differences in three of the AA-derivatives screened.
GPCR-mediated Ca 2+ independent release of PGE2 from astrocytic cultures
Given that we and others have previously implicated Ca 2+ -dependent astrocyte lipid release in vasoregulation (Zonta et al., 2003; Takano et al., 2006; Gordon et al., 2008) , it was surprising that PGE2 was released via a Ca 2+ -independent mechanism. Since HPCL/MS/MS methods required large quantities of cells to detect PGE2, whereas the PGE2 ELISA assay accurately can detect PGE2 release in 24-well cultures, we used ELISA to explore and define the Ca 2+ dependence of astrocytic PGE2 release. Because iPLA2 is essential for Ca 2+ independent liberation of AA derived lipids, we first assessed whether knockdown of iPLA2 via viral transduction would inhibit astrocytic release of PGE2. In the presence of CPA (20 μM), ATP (100 μM) failed to induce PGE2 release in astrocytic cultures viral transduced with shRNA, whereas a significant increase in the release of PGE2 was observed in the presence of ATP and CPA in control shRNA cultures ( Figure 3A) .
Knockdown of iPLA2 via shRNA viral transduction was confirmed with western blot analysis ( Figure 3B ).
Since cultured astrocytes express mGluR5 (Balazs et al., 1997; Silva et al., 1999; Gebremedhin et al., 2003) , we next tested whether tACPD (100 μM) and AMPA (100 μM) in the presence and absence of CPA evoked PGE2 release. In the absence of CPA, little to no release of PGE2 was observed ( Figure 3C) . However, when CPA blocked release of internal stores of Ca 2+ , tACPD and AMPA significantly increased PGE2 release ( Figure 3C) .
The most abundant mGluR receptors expressed by astrocytes are mGluR3 and mGluR5 (Petralia et al., 1996; Aronica et al., 2000; Tamaru et al., 2001) . However, mGluR5 is developmentally regulated and is not expressed by astrocytes in the adult brain, whereas mGluR3 is persistently expressed at high levels throughout adulthood (Sun et al., 2013) . It is therefore important to know whether activation of mGluR3 can induce Ca 2+ -independent PGE2 release since activation of this receptor has recently been shown to induce Ca 2+ transients in adult hippocampal astrocytes (Haustein et al., 2014; Tang et al., 2015) . In the presence of CPA, both NAAG and LY379268 (mGluR3 agonists) (Wroblewska et al., 1997; Bond et al., 1999 ) evoked a significant increase in the release of PGE2, whereas the same agonists failed to release PGE2 in the absence of CPA ( Figure 3D) . This is interesting because it shows that activation of an astrocytic Gi-coupled receptor can release gliotransmitters in a Ca 2+ -independent mechanism.
To extend the observation to human astrocytes, we performed the same experiments in primary cultured astrocytes harvested from embryonic tissue (Windrem et al., 2004; Windrem et al., 2008; Han et al., 2013) . After pharmacologically assessing iPLA2 activity in rat astrocytes ( Figure 1F) , we evaluated iPLA2 expression in all the culture models. Western blot analysis showed that iPLA2 expression was not limited to rat astrocytic cultures, but was also readily expressed in both human and mouse astrocytes ( Figure 3E ). In the presence of CPA, ATP evoked a significant PGE2 release from cultured human astrocytes, whereas little to no release was observed with ATP alone (Figure 3F) . Likewise, co-application of tACPD and AMPA showed the same effect ( Figure 3F) . Taken together, these findings show that ATP or mGluR3 activation lead to Ca 2+ -independent PGE2 release and that iPLA2 is expressed in mouse, rat, and human astrocytic cultures.
Ca 2+ -independent astrocytic lipid release enhances mEPSPs via Kv channel blockade
Experiments thus far have demonstrated that cultured astrocytes in response to agonist exposure can indeed release lipids in a Ca 2+ -independent pathway. In fact, the in vitro analysis showed that agonist-induced Ca 2+ increases impede PGE2 release as CPA, BAPTA, and CMZ pretreatment potentiated PGE2 release.
Earlier studies have shown that AA and its metabolite, PGE2, inhibit neuronal Kv current (Horimoto et al., 1997; Nicol et al., 1997; Evans et al., 1999) and thereby enhance excitability (Sekiyama et al., 1995; Chen and Bazan, 2005; Sang et al., 2005) . We next evaluated whether astrocytic lipid release also inhibits neuronal Kv current and enhances excitability in acute hippocampal slices. We performed dual patch-clamp recordings of pairs of CA1 pyramidal neurons and astrocytes in acute hippocampal brain slices prepared from 12-18 day old mice ( Figure 4A) . In order to isolate transiently active potassium currents, we used voltage ramps within approximately 100ms, which is fast enough to capture transient A-currents (Phillips et al., 2018) . It is worth noting that the I-V ramp is a good way to discern what voltage deflection in outward current the drugs might effect (Jackson and Bean, 2007) . We recorded Kv currents in CA1 neurons as an assay for astrocytic lipid release, since Kv currents are sensitive to AA and/or its metabolites (Villarroel and Schwarz, 1996; Carta et al., 2014) . Kv currents were isolated by adding 1 mM QX314 in the patch pipette to block sodium channels (Talbot and Sayer, 1996; Kim et al., 2010) and imposing a voltage ramp (from -100 mV to 50 mV) every 5 seconds to continuously monitor changes in Kv channel current (Ji et al., 2000; Rangroo Thrane et al., 2013b; Carta et al., 2014) as an assay for agonist-induced astrocytic lipid release ( Figure 4A ). As expected, direct puffing of PGE2 (50 μM) and AA (50 μM) with a micropipette induced changes in Kv current. The Kv current was significantly reduced in the presence of both PGE2 (50 μM) and AA (50 μM), which is consistent with previous studies (Evans et al., 1999; Carta et al., 2014) ( Figure 4B-C) .
Is astrocytic release of AA and its metabolites sufficient to increase CA1 neuronal excitability? To assess the effects of astrocytic Ca 2+ signaling on neighboring neuronal Kv channels, we first stimulated astrocytes with ATP and TFLLR-NH2, an agonist of proteaseactivated receptor-1 (PAR1) that is primarily expressed by astrocytes (Shigetomi et al., 2008) . ATP (100 μM) induced a comparable change to neuronal Kv when BAPTA (50 μM) was present in the astrocyte patch pipette, but not when it was absent ( Figure 4B-C) . A similar transient decrease in Kv current was observed when astrocytes were activated by TFLLR-NH2 (30μM).
Again, the reduction in neuronal Kv currents was only detected when TFLLR was applied when BAPTA was added to the astrocytic pipette solution (Fig. 4B-C) . To selectively activate astrocytic Ca 2+ signaling, we next employed MrgA1 transgenic animals (MrgA1 +/-), which express the exogenous Gq-coupled MRG receptor (MrgA1) under control of the GFAP promoter. The MrgA1 agonist, Phe-Met-Arg-Phe amide (FMRF), mobilizes intracellular astrocytic Ca 2+ stores, enabling assessment of the effects of astrocytic Ca 2+ signaling on neighboring neuronal Kv currents.
Although FMRF (15 μM), induces potent and selective increases in astrocytic cytosolic Ca 2+ in hippocampal slices (Fiacco et al., 2007; Agulhon et al., 2010; Wang et al., 2012) , no detectable changes in neuronal Kv current were detected when the pipette used to patch the astrocyte did not contain BAPTA (Figure 4B-C) . However, when BAPTA was included in the astrocyte patch pipette, a marked decrease in neuronal Kv current was evoked by FMRF exposure (Figure 4B-C) . Thus, these observations suggest that astrocytes can modulate neuronal Kv current via previously undocumented Ca 2+ -independent lipid release.
To assess whether a decrease in neuronal Kv current is a consequence of Ca 2+independent astrocytic lipid release, we next employed specific lipid receptor antagonists for PGE2 and endocannabinoids. Since PGE2 receptors 1, 2, 3, and 4 are expressed on hippocampal pyramidal neurons (Andreasson, 2010; Maingret et al., 2017) , we employed AH6809, a PGE2 EP1,2, and 3 antagonist (Abramovitz et al., 2000; Ganesh, 2014) , and GW627368, a PGE2 EP4 antagonist (Jones and Chan, 2005; Wilson et al., 2006) . In the presence of AH6809 (10 μM) and GW627368X (3 μM) in the perfusion solution, the TFLLR, FMRF, and ATP Ca 2+ -independent induced decrease in neuronal Kv current was abolished ( Figure 4C) ; In contrast, AM251 (5 μM), a CB1 antagonist, failed to abolish the decrease in Kv current ( Figure 4C) . Taken together, these data suggest that the observed decrease in neuronal Kv current is a result of astrocytic Ca 2+independent release of PGE2. Interestingly, the presence or absence of BAPTA in the astrocytic pipette solution also modulated agonist-induced changes in neuronal membrane potential ( Figure 4D) . Without BAPTA in astrocytes, TFLLR induced hyperpolarization (1.4 ± 0.26 mV) ( Figure 4D) , as has been shown in a previous study to be due to a decrease in extracellular potassium (Wang et al., 2012) . However, with BAPTA present in astrocytes, TFLLR induced depolarization (2.1 ± 0.25 mV) ( Figure 4D) , an effect we suggest might be attributable to the blockage of potassium current.
PGE2 has previously been shown to enhance neuronal mEPSPs (Sekiyama et al., 1995) (Sang et al., 2005) . We here found that TFLLR-induced activation of astrocytes in slices triggered a decrease in mEPSPs in the normal hippocampal slices (Figure 5A) , but induced an increase in the amplitude and frequency of mEPSPs, but only when BAPTA was added to the astrocytic pipette solution (Figure 5B) . This observation supports the notion that astrocytic Ca 2+independent lipid release may function as a signaling mechanism capable of modulating synaptic activity by blocking Kv channels, which in turn may increase the frequency and amplitude of mEPSPs. It is interesting to note that TFLLR has opposing effects on mEPSP amplitude and frequency dependent upon the level of calcium (Figure 5C-D) ; suggesting calcium deletion provides a pathway to PGE2 enhancement of neuronal excitability.
DISCUSSION
Lipidomics has the potential to open exciting new avenues within the field of gliotransmission. In the present study, we utilized a series of lipidomics methodologies which showed that Ca 2+ chelation followed by glutamatergic or purinergic receptor stimulation produces a variety of lipids in astrocytes and drives the release of astrocytic PGE2, which serves to modulate neuronal Kv channels resulting in enhanced synaptic activity detected as an increase in mEPSPs ( Figure 5) . Multiple lines of evidence presented here also support the hypothesis that this agonistinduced Ca 2+ -independent lipid release in astrocytes is iPLA2 dependent. In addition, we demonstrated that receptor mediated Ca 2+ -independent PGE2 release was preserved across rat and human astrocytes (Figure 3) . The observations reported here represent, to our knowledge, the first demonstration of Ca 2+ -independent release of gliotransmitters in the form of lipid mediators and adds a novel dimension to our understanding of glial-neuronal communication.
Importance of iPLA2 pathway in Ca 2+ -independent astrocytic lipid production
To date, many studies have shown the multifaceted functions of PLA2 in the CNS, but iPLA2 is the major PLA2 isoform, and accounts for 70% of the PLA2 activity in the rat brain (Yang et al., 1999) . Although the effects of cPLA2 activation is best documented (Malaplate-Armand et al., 2006; Schaeffer and Gattaz, 2007; Kim et al., 2008) , iPLA2 has also been shown to participate in phospholipid remodeling (Sun et al., 2004) , regulate hippocampal AMPA receptors and learning and memory (Menard et al., 2005) , regulate store-operated Ca 2+ entry in cerebellar astrocytes (Singaravelu et al., 2006) , and provide neuroprotection against oxygen glucose deprivation (Strokin et al., 2006) . Astrocytes express both isoforms of PLA2 (Sun et al., 2005) . Numerous studies have documented that PLA2 is activated in response to agonist induced Ca 2+ signaling and mediates release of AA and/or its metabolites from astrocytes (Bruner and Murphy, 1990; Stella et al., 1994; Stella et al., 1997; Chen and Chen, 1998) . Here, we focused on the largely unexplored iPLA2 lipid pathway in astrocytes. Given the ubiquitous expression of iPLA2 in astrocytes throughout the brain, the argument can be made that it may have multiple signaling roles. Data presented here provide strong evidence for iPLA2 in agonist-induced Ca 2+independent astrocyte lipid release ( Figure 6) .
Rapid signaling may be the key to astrocytic release of PGE2 that modulates neuronal Kv channels
An important aspect of astrocytic gliotransmitter release is timing. Agonist-induced astrocytic Ca 2+ increases occur on a slow time scale of seconds (Cornell-Bell et al., 1990; Wang et al., 2006; Srinivasan et al., 2015) and Ca 2+ is a key step in gliotransmitter release, (Parpura et al., 1994; Bezzi et al., 1998; Kang et al., 1998) , such as ATP (Coco et al., 2003; Parpura and Zorec, 2010; Illes et al., 2019) and D-Serine (Mothet et al., 2000; Yang et al., 2003; Li et al., 2018; Neame et al., 2019) . Recently, we have shown that agonist-induced astrocytic Ca 2+ signaling could modulate synaptic activity by active K + uptake resulting in a transient lowering of extracellular K + and depression of synaptic activity (Wang et al., 2012) . More recently, we demonstrated that astrocytes can modulate a rapid form of synaptic activity (³500ms) via 2AG release upon mGluR 3 receptor stimulation (Smith et al., 2019) . Because receptor mediated astrocytic Ca 2+ drives K + uptake and release of gliotransmitters, these processes must, therefore, occur over a relatively prolonged time course (>500ms). However, agonist-induced Ca 2+independent iPLA2 lipid release, does not require mobilization of intracellular Ca 2+ stores and this signaling pathway has the potential to signal on a much faster time scale (possibly 10s of milliseconds). We speculate that iPLA2 mediated lipid release may act as a feedback system that enhances fast synaptic transmission in the immediate short-term or under minimal activity conditions with subsequent activity-mediated calcium increases serving as a brake to the calmodulin-dependent inhibition of iPLA2. The slower Ca 2+ -dependent release of gliotransmitters and K + uptake is more suited toward the slow and widespread modulation of brain activity (typically inhibition) that occurs in the setting of, for example, activation of locus coeruleus and associated norepinephrine release (Bekar et al., 2008; Ding et al., 2013) .
Voltage-gated potassium channels are located on the dendrites of hippocampal pyramidal neurons (Johnston et al., 2000) , and these channels play a major role in controlling dendritic excitability by modulating the amplitude of mEPSPs. A morphological study found that the density of Kv channels in the dendrites of pyramidal neurons increased 5-fold from the soma to the most distal point measured in the apical dendrites (Hoffman et al., 1997) . Closure of voltage-gated K + currents will enhance EPSPs, possibly explaining why PGE2 enhances synaptic transmission and LTP (Sang et al., 2005) .
Lipidomics models as a guide for future gliotransmitter discoveries
Lipidomics is one of the fastest-growing branches of the metabolomics fields with a potential to identify and characterize thousands of lipid species throughout the body, especially in the brain, where the total mass of the structure is made primarily of lipids (Sinclair, 1975) . The surface to volume index of astrocytes is larger than most other cell types based on complex fine structure of laminate, fine astrocytic processes: It is logical that many gliotransmitters would also be lipids. HPLC/MS/MS lipidomics techniques have provided a means to identify specific lipid species with an accuracy that eluded former techniques; however, many of those previously used techniques such as radio-labeled fatty acids and ELISAs are still powerful tools in the field. Here, we have used a combination of these techniques to critically test the hypothesis that lipids are produced in and released from astrocytes in a Ca 2+ -independent manner. Our focus here was on the release of PGE2; however, there were 15 additional lipids identified that were upregulated under the same conditions. It is also important to note, that of the 30 lipids detected in this small, targeted HPLC/MS/MS assay, 14 did not change supporting the specificity of GPCR stimulated, Ca 2+ -independent lipid production. Interestingly, 2 of the lipids released in response to agonist exposure, N-arachidonyl taurine and N-palmitoyl tyrosine, were recently shown to activate TRPV4 (Raboune et al., 2014) . Emerging evidence suggests a role for a TRPV4/AQP4 complex in regulation of hypo-osmotic stress in astrocytes (Benfenati et al., 2011) . The lipidomics data provided here can provide unbiased insight into other signaling mechanisms that involve astrocytic-derived lipid modulators (Figure 2) .
In conclusion, Ca 2+ -independent astrocytic lipid release constitutes a largely unexplored participant in complex neuro-glial signaling interactions. The analysis presented here adds a new dimension to agonist-induced Ca 2+ signaling by demonstrating that several Gq and Gi-linked receptors can mediate release of lipid modulators and that increases in cytosolic Ca 2+ acts as a break that prevents PGE2 release. 
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